Goldman Sachs Russias Crude Exports Remain Resilient Despite Latest US Sanctions EasyJet Faces Wider FirstHalf Losses as Iran Conflict Drives Fuel Costs and Dampens Summer Demand JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India TFCI What Investors Should Know EU and Mexico Seal Updated Trade Deal to Diversify Supply Chains Amid Global Tensions Standard Chartered Announces Significant Job Cuts in Corporate Functions to Boost Efficiency Jim Cramer Weighs In on Hasbro HAS Stock Key Insights iHeartMedia IHRT Q1 2026 Earnings EPS Misses Estimates Stock Rallies Despite Loss Brookfield Renewable Corporation Q1 2026 Earnings EPS Misses Estimates as Renewable Energy Market Faces Headwinds Dragonfly Energy Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Quarter Banner Corporation BANR Q1 2026 Earnings Earnings Beat Expectations on Strong Operating Performance T Stamp IDAI Q1 2026 Earnings EPS Miss Widens as Revenue Details Remain Undisclosed BDTX Q1 2026 Earnings EPS Beat but Stock Retreats 36 on Biotech Volatility Chesapeake Utilities CPK Edges Higher Amid Steady Utility Sector Performance A Paradise Acquisition Corp Unit APADU Holds Steady at 100 Amid Neutral Trading Unity Bancorp UNTY Slides 13 as Banking Sector Headwinds Mount Barrett Business Services Inc BBSI Slips Over 2 as Stock Tests Key Support Zone Title Ridgetech Inc RDGT Surges 1395 as Bulls Test Key Resistance at 154 Digi International Inc DGII Surges Over 3 as Positive Momentum Builds AXIL Brands Finds Floor at Support Eyes Resistance Amid Low Volume J W Mays Inc MAYS Rallies 326 Nears Resistance at 4489 Support and Technical Outlook ITHAW Warrants Hold Steady at 024 as ITHAX Acquisition Corp III Nears Resistance Li Bang International LBGJ Posts Modest Gain Holds Above Key 085 Support Fonar Corporation FONR Holds Steady Near Support as Technical Indicators Signal Caution SpaceXs Starlink Revenue Stream Could Be Key to Valuation Amid Potential Nasdaq Listing AIHS Q1 2026 Earnings Reported Net Loss Persists Amidst Operational Challenges Design Therapeutics DSGN Consolidates Near Support After Marginal Decline